Steffens Maryke S, Kaufman Jessica, Bolsewicz Katarzyna T, Vidmar Suzanna, Christou-Ergos Maria, Sabahelzain Majdi M, Leask Julie, Boxall Justin, Beard Frank, Danchin Margie
National Centre for Immunisation Research and Surveillance, Kids Research, Sydney Children's Hospitals Network, Westmead, NSW 2145, Australia.
The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2145, Australia.
Vaccines (Basel). 2025 May 19;13(5):540. doi: 10.3390/vaccines13050540.
: Influenza vaccines are recommended and free in Australia for children aged <5 years, but uptake remains low at 25.8% compared to the targets of 40% and 50%. National data on barriers hindering paediatric influenza vaccination can inform strategies to improve uptake. The aim of this study was to measure barriers to influenza vaccination in Australian children aged <5 years. : A national, cross-sectional survey of parents of children aged <5 years was conducted in March/April 2024. Parents were recruited using an online panel and asked about their intention to get an influenza vaccine for their youngest child in the upcoming influenza season. An adapted version of the validated Vaccine Barriers Assessment Tool measured 14 influenza vaccination barriers. Analysis assessed the prevalence of barriers and differences between parents intending to and those unsure or not intending to vaccinate by calculating the prevalence difference and 95% confidence interval. : A total of 2000 parents were recruited nationally. The most common barrier was parents feeling distressed when thinking about vaccinating their child against influenza (66.1% of intending parents, 65.6% of unsure/not intending parents). The barrier with the largest difference between intending and not intending/unsure parents was not prioritising their child's influenza vaccination (47.2% vs. 6.1%, PD = 41.1 ppts, 95% CI: 35.9%, 46.3%). Other barriers with large differences were parents not feeling guilty if their unvaccinated child got influenza (41.5% vs. 7.5%, PD = 34.0 ppts, 95% CI: 28.8%, 39.1%) and parents not believing that influenza vaccines are effective (31.3% vs. 3.0%, PD = 28.2 ppts, 95% CI: 23.6%, 32.9%). : Parents should be encouraged and supported to prioritise influenza vaccination alongside routine childhood vaccines in campaigns that emphasise disease risk and the importance, safety and effectiveness of influenza vaccination, and by optimising access to influenza vaccination. We recommend conducting similar surveys regularly to monitor trends in parental barriers to childhood influenza vaccination.
在澳大利亚,5岁以下儿童可免费接种流感疫苗,且该疫苗是被推荐接种的,但与40%和50%的目标相比,疫苗接种率仍较低,仅为25.8%。关于阻碍儿童接种流感疫苗的障碍的全国性数据可为提高接种率的策略提供参考。本研究的目的是衡量澳大利亚5岁以下儿童接种流感疫苗的障碍。
2024年3月/4月,对5岁以下儿童的家长开展了一项全国性横断面调查。通过在线小组招募家长,并询问他们在即将到来的流感季节为其最小的孩子接种流感疫苗的意愿。使用经过验证的疫苗障碍评估工具的改编版本来衡量14种流感疫苗接种障碍。分析通过计算患病率差异和95%置信区间,评估了障碍的患病率以及打算接种和不确定或不打算接种的家长之间的差异。
全国共招募了2000名家长。最常见的障碍是家长在考虑为孩子接种流感疫苗时感到苦恼(打算接种的家长中有66.1%,不确定/不打算接种的家长中有65.6%)。打算接种和不打算接种/不确定接种的家长之间差异最大的障碍是没有将孩子的流感疫苗接种列为优先事项(47.2%对6.1%,患病率差异=41.1个百分点,95%置信区间:35.9%,46.3%)。其他差异较大的障碍包括家长如果未接种疫苗的孩子感染流感不会感到内疚(41.5%对7.5%,患病率差异=34.0个百分点,95%置信区间:28.8%,39.1%)以及家长不相信流感疫苗有效(31.3%对3.0%,患病率差异=28.2个百分点,95%置信区间:23.6%,32.9%)。
应鼓励和支持家长在强调疾病风险以及流感疫苗接种的重要性、安全性和有效性的活动中,将流感疫苗接种与儿童常规疫苗接种一同列为优先事项,并优化流感疫苗接种的可及性。我们建议定期开展类似调查,以监测家长对儿童流感疫苗接种障碍的趋势。